AGC Bio se­cures lentivi­ral con­tract; Ther­mo Fish­er to make Cy­bin as­set

Last week
Manufacturing

Ex­clu­sive: Drug com­pounder Em­pow­er was built on risky short­cuts, ex-em­ploy­ees and in­spec­tions al­lege

Last week
Pharma
In Focus

Ex­clu­sive: 17 health sys­tems are work­ing with Abun­dant Ven­ture Part­ners to de­vel­op tech

Last week
Health Tech

Ex­clu­sive: Data­vant to ac­quire re­al-world da­ta spe­cial­ist Ae­tion, dou­bling life sci­ences team

Last week
Deals
AI

Up­dat­ed: Mer­ck KGaA con­tin­ues US tar­iff sur­charge but at a 'de­creased' rate 

Last week
China
Pharma

Bio­haven stock sinks on three-month de­lay for neu­ro drug's FDA ap­proval de­ci­sion

Last week
Pharma
FDA+

Hen­grui, one of Chi­na's lead­ing biotechs, an­tic­i­pates $1.2B in pro­posed Hong Kong list­ing

Last week
Financing
China

RFK Jr. de­fends HHS staff cuts, re­or­ga­ni­za­tion plans in House, Sen­ate hear­ings

Last week
Pharma
FDA+

RFK Jr. says his opin­ions of vac­cines are ‘ir­rel­e­vant.’ For­mer FDA chief Califf dis­agrees

Last week
Pharma
FDA+

Sanofi touts $20B in­vest­ment in US over five years

Last week
Pharma
Manufacturing

FDA gives Ab­b­Vie ac­cel­er­at­ed ap­proval for an­ti­body-drug con­ju­gate in lung can­cer

Last week
Pharma
FDA+

SK, Car­lyle bol­ster blue­bird bio bid; Theri­ni Bio rais­es $39M

Last week
News Briefing

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

Last week
Startups
Deals

GSK to pay $1.2B up­front to snag Boston Phar­ma’s mid-stage MASH hope

Last week
Deals
Pharma

No­vo turns to Septer­na for oral obe­si­ty med­i­cines in deal worth up to $2.2B

Last week
Deals
Pharma

Ad­vo­ca­cy groups and ex­perts call for decade-long ban on germline edit­ing

Last week
R&D
Cell/Gene Tx

Oma­da Health joins the dig­i­tal health IPO cor­ral

Last week
Health Tech

CRISPR patent spat re­vived by fed­er­al ap­peals court rul­ing

Last week
Cell/Gene Tx
Law

HHS fo­cus­es on 'trans­paren­cy' in third-round IRA ne­go­ti­a­tion guid­ance

Last week
Pharma
Law

Some gener­ics, biosim­i­lar drug­mak­ers say they can with­stand tar­iff im­pact

Last week
Pharma
Manufacturing

Arc­turus to pri­or­i­tize mR­NA ther­a­peu­tics in bid to boost rare dis­ease pro­grams

Last week
R&D

Cy­to­ki­net­ics gets an 'in­cre­men­tal' win for de­layed heart drug

Last week
R&D

Ax­some's $570M loan with Black­stone; Al­tim­mune makes its own cred­it deal

Last week
News Briefing

Unit­ed­Health Group CEO An­drew Wit­ty steps down

Last week
People
Health Tech
First page Previous page 2345678 Next page Last page
A service from the Financial Times